Thema
COVID-19
Therapeutics. Pharmacology
27
SARS-CoV-2
11
coronavirus
5
dexamethasone
5
corticosteroids
3
antivirals
2
asthma
2
corticosteroid
2
drug repurposing
2
therapeutics
2
tocilizumab
2
treatment
2
CCR5/CXCR3
1
COPD
1
COVID-19 ARDS
1
PBPK modelling
1
PXR
1
SARS-Cov-2
1
TAK-779
1
TriNetX database
1
acute respiratory distress syndrome
1
adjunctive therapy
1
adults (MeSH)
1
anti-IL5 drugs
1
antibiotic
1
antidepressants
1
atovaquone
1
baricitinib
1
bioinformatics analyses
1
clinical improvement
1
clinical trial
1
clinical trials
1
clomipramine
1
cohort
1
comorbidity
1
cost-effectiveness
1
critically ill/pulmonary fibrosis manifested
1
cytokine storm
1
cytokines
1
dexamethason implant
1
diabetic macular edema
1
diagnostics
1
diffuse alveolar damage of the lung
1
double blind
1
drug induced liver injury
1
drug monitoring
1
drug prescription
1
drug treatment
1
drug-drug interactions
1
mehr ...